옵션 체인은 다양한 행사가격과 만기일에 대한 ON Semiconductor의 주식 옵션 주요 데이터를 보여줍니다. 트레이더들은 이 정보를 사용하여 잠재적 거래를 분석하고 ON Semiconductor에 대한 시장 심리를 평가합니다..

ON Semiconductor (NASDAQ:ON) 주식, 옵션 체인

ON Semiconductor

Onsemi is a supplier of power semiconductors and sensors focused on the automotive and industrial markets. Onsemi is the second-largest power chipmaker in the world and the largest supplier of image sensors to the automotive market. While the firm used to be highly vertically integrated, it now pursues a hybrid manufacturing strategy for flexible capacity. Onsemi is pivoting to focus on emerging applications like electric vehicles, autonomous vehicles, industrial automation, and renewable energy.

Earnings

News

Guidance

Tech

온 세미컨덕터(NASDAQ:ON)의 주식은 2024 회계연도 3분기 매출이 전년 대비 19.2% 감소한 17억 6천만 달러를 기록하였으며, 애널리스트 컨센서스 추정치인 17억 5천만 달러를 상회했다.

온 세미컨덕터는 매출 하락과 마진 압박 속에도 3분기 매출과 EPS가 예상치 상회

Pre-Market Outlook

Markets

Trading Ideas

월요일 아침 (현지 시간 기준) 미국 주식 선물이 상승하고 있는 가운데, 오늘 투자자의 관심을 끌 수 있는 일부 주식은 다음과 같다: 1. 월스트리트는 온 세미컨덕터(NASDAQ:ON)가 개장 전 분기 실적으로 주당 97센트의 순이익과 17억 5천만 달러의 매출로 보고할 것으로 예상하고 있다. 온 세미컨덕터의 주식은 애프터 마켓에서 0.3% 상승한 71.44달러로 거래되었다.

월요일 주목해야 할 주식: 온 세미컨덕터, 포드 자동차, 센터포인트 에너지 및 2종목

Analyst Color

Equities

Large Cap

Mid Cap

AFRM

CHWY

CRWD

DELL

DKNG

DLTR

ENPH

EXPE

FSLR

GNRC

MRNA

SNOW

골드만삭스는 기대 이상의 실적 발표가 있을 경우 특히 공매도세가 높은 20개의 주식을 선정하여 쇼트 스퀴즈(공매도 압박)가 발생할 가능성이 있다고 밝혔다. 이는 트레이더들에게 기회를 제공한다.

골드만삭스, 3분기 실적 시즌에서 공매도 압박 기회가 전망되는 상위 20종목

ON Semiconductor Corporation - Common Stock

ON Semiconductor Corp

Old National Bancorp

One Bio Corp

Old National Bancorp - Depositary Shares, Each Representing a 1/40th Interest in a Share of Series C Preferred Stock

Old National Bancorp - Depositary Shares, Each Representing a 1/40th Interest in a Share of Series A Preferred Stock

SPARK THERAPEUTICS ORD

ON4 COMMUNS INC by On4 Communications, Inc.

On4 Communications Inc

Onconetix Inc

141 CAPITAL INC by 141 Capital, Inc.

Oncorus Inc rdinary Shares

ONCOSEC MEDICAL INC NEW by OncoSec Medical Incorporated

OncoSec Medical Inc

Oncternal Therapeutics, Inc. - Common Stock

Oncternal Therapeutics Inc

Oncolytics Biotech Inc

ProShares On-Demand ETF

Ondo - United States Dollar

Sushi Ginza Onodera, Inc

Ondas Holdings Inc

Harmony

OneMeta Inc

SPDR Russell 1000 Momentum Focus ETF

Fidelity Nasdaq Composite Index ETF

Harmony - TrueUSD

SPDR Russell 1000 Low Volatility Focus ETF

OneWater Marine Inc. - Class A Common Stock

OneWater Marine Inc

Onex Corp

SPDR Russell 1000 Yield Focus ETF

ONE 4 ART LIMITED NEW by One 4 Art Limited

Onfolio Holdings Inc

ONFOLIO HLDGS INC PFD A by Onfolio Holdings Inc.

Ontology Gas

ONGOLD RESOURCES LTD by ONGold Resources Ltd.

ONGold Resources Ltd

DeepOnion

Onity Group Inc

ONBUFF

Orion Office REIT Inc

ProShares Online Retail ETF

Onamba Co Ltd

OneMedNet Corp

Global X Adaptive U.S. Risk Management ETF

On Holding AG

ONCOLOGY PHARMA INC by Oncology Pharma Inc.

Oncology Pharma Inc

Oncopeptides AB

ONS Acquisition Corp

ONASSIS HOLDINGS CORP by Onassis Holdings Corp.

Onassis Holdings Corp

ONE SOFTWARE TECHNOLOGIES by One Software Technologies Ltd.

One Software Technologies Ltd

ONSTON

Ontology

ON24 Inc

Onto Innovation Inc

BLACKROCK OIL CORP by Blackrock Oil Corporation

Blackrock Oil Corp

OXFORD NANOPORE TECH PLC by Oxford Nanopore Technologies PLC

Oxford Nanopore Technologies PLC

ONUS

ONLINE VACATION CTR HLDGS by Online Vacation Center Holdings Corp.

Online Vacation Center Holdings Corp

Organovo Holdings Inc

Oneview Healthcare PLC

Onward Medical NV

ownix

Onyx Corp

Onyx Gold corp

Ontex Group NV

ONTEX GROUP NV UNSP/ADR by Ontex Group NV

Onyx Acquisition Co I rdinary Shares - Class A

Onyx Acquisition Co I

Onyx Acquisition Co I Units (1 Ord Class A & 1/2 War)

Onyx Acquisition Co I Warrants (30/11/2028)

ORGANIZACION SORIAA B by Organizacion Soriana SAB DE CV

Organizacion Soriana SAB de CV

ON SEMICONDUCTOR ORD

With the first polling places about to close in what is <a href="https://www.benzinga.com/general/politics/24/11/41748843/trump-holds-edge-in-betting-markets-on-election-day-while-experts-call-tight-race-for-harris">expected to be a neck-and-neck election night</a>, reports from Georgia and Michigan say those two swing states are seeing record-high turnout.
What Happened: Turnout in Philadelphia is also reported to be extremely high, with Reuters reporting turnout as much as 50% higher in some precincts than in 2020. A big win in Philadelphia would go a long way toward delivering Pennsylvania &#8211; the largest and tightest swing state &#8211; to Kamala Harris.
At 4:39 p.m. EDT, Donald Trump wrote on Truth Social: &#8220;A lot of talk about massive CHEATING in Philadelphia. Law Enforcement coming!!!&#8221; 
A Philadelphia police spokesman <a href="https://fortune.com/2024/11/05/donald-trump-claims-cheating-police-philadelphia-pennsylvania/">told Fortune</a> they are &#8220;not aware of anything at this time.&#8221; 
Charlie Kirk of pro-Trump group Turning Point Action wrote earlier on X: &#8220;Turnout is mixed and not where we want it to be. We need more people to vote.&#8221;
Also Read: <a href="https://www.benzinga.com/general/politics/24/11/41725742/2024-election-stakes-potential-sweeps-split-outcomes-in-congressional-presidential-races">2024 Election Stakes: Potential Sweeps, Split Outcomes In Congressional, Presidential Races</a>
Politico is <a href="https://www.politico.com/live-updates/2024/11/05/2024-elections-live-coverage-updates-analysis/turnout-high-in-georgia-00187458">reporting</a> that turnout in Georgia is on track to surpass 2020, and The Hill <a href="https://thehill.com/homenews/campaign/4973132-michigan-on-pace-to-break-voter-turnout-records-official-says/">says</a> that Michigan may break turnout records.
Why It Matters: High turnout in Philadelphia would be good news for Harris, but even a loss in Pennsylvania would not be fatal to Trump if he performs well in other swing states.
Georgia, Michigan and Pennsylvania were all key to Joe Biden&#8216;s victory in 2020.
Read Next
<ul>
<li><a href="https://www.benzinga.com/general/politics/24/11/41728436/trump-vs-harris-2024-election-deadlocked-final-emerson-poll-shows-one-candidate-with-small-edge-">Trump Vs. Harris: 2024 Election Deadlocked, Final Emerson Poll Shows One Candidate With Small Edge Among Independents</a></li>
</ul>
Image: Shutterstock.

Politics

High Turnout Reported In Key States, Trump Baselessly Alleges 'Massive CHEATING' In Philadelphia

A new study <a href="https://tandfonline.com/doi/full/10.1080/21507740.2024.2303154">published</a> in AJOB Neuroscience reveals that most Americans are supportive of <a href="https://www.benzinga.com/topic/psilocybin">psilocybin</a> use, a psychedelic compound derived from "magic mushrooms," in supervised, licensed settings. As PsyPost <a href="https://www.psypost.org/majority-of-americans-support-supervised-use-of-psilocybin-for-mental-health-and-well-being/">reported</a>, this approval, spanning across political lines, underscores public openness to the controlled use of <a href="https://www.benzinga.com/topic/psychedelic-assisted-therapies">psilocybin for mental health treatment</a> and general well-being, despite remaining concerns for policy caution.
Psilocybin, a <a href="https://www.benzinga.com/topic/federal-schedule-i">Schedule 1</a> drug in the U.S., has long been classified as having a high potential for abuse with no accepted medical use. However, <a href="https://www.benzinga.com/markets/cannabis/24/10/41216395/could-psilocybin-be-a-game-changer-for-millions-battling-depression-new-study-says-yes">recent clinical studies</a> suggest it may help alleviate symptoms of conditions such as treatment-resistant depression when administered under professional supervision. Unlike many medications, psilocybin is considered non-addictive, and studies have found it may also <a href="https://www.benzinga.com/markets/cannabis/24/09/41004196/psilocybin-found-to-be-as-effective-as-lexapro-in-treating-depression-researchers-say">enhance overall well-being</a> in healthy individuals.
This research aimed to explore public perceptions of psilocybin amid <a href="https://www.benzinga.com/markets/cannabis/24/08/40447902/psychedelics-and-mental-health-fda-stalls-but-states-forge-ahead">recent legislative progress</a>, such as Oregon&#8217;s law <a href="https://www.benzinga.com/markets/cannabis/20/11/18204455/oregon-becomes-first-us-state-to-decriminalize-drug-possession-begins-psilocybin-program">allowing its therapeutic use</a>. Researchers surveyed 805 Americans, aged 18 to 92, providing background on psilocybin's effects, origin and legal status before asking about support for nationwide legalization.
<h3 class="wp-block-heading">Mental Health Treatment Vs. Well-Being Enhancement</h3>
Participants were presented with two scenarios involving supervised psilocybin use: one for mental health treatment and the other for personal well-being. A strong 89% of participants supported psilocybin use for mental health treatment, while 85% approved its use for well-being enhancement. Though medical use garnered slightly more support, both scenarios saw broad endorsement.
The results show bipartisan support for supervised psychedelic therapy, with younger and more liberal adults showing stronger approval. Older adults and conservatives were more cautious, while those valuing empathy and care were more supportive of psilocybin use in therapy
<h3 class="wp-block-heading">Navigating Caution Amid The Psychedelic Renaissance</h3>
The study also sheds light on the importance of tempering enthusiasm with scientific rigor. According to the researchers, the growing interest in psychedelics comes with the risk of overhyping benefits. Given the early stage of the field, both over- and understatements of trial results are not uncommon. As they noted, while psilocybin shows significant medical potential and a strong safety profile, current evidence doesn&#8217;t support rash conclusions beyond its use in the right context.
While the findings suggest broad public support for supervised psychedelic use, the study focused only on licensed environments, excluding unsupervised or recreational use. Future research could explore attitudes toward these higher-risk aspects.
<h3 class="wp-block-heading">Building Trust And Policy For The Future</h3>
The study authors stressed the need for trust-building and caution in shaping future policies. "If the field can overcome scientific inaccuracies, pursue rigorous research, and build trust—then psychedelics such as psilocybin may one day be seen as a mainstream means to treat mental illness and possibly also to promote overall well-being," they concluded.
With public support reaching bipartisan levels, the potential for psilocybin to become part of standard mental health care is closer to reality than ever, signaling a transformative shift in mental health treatment in the U.S.
Cover image made with AI

Cannabis

Psychedelics

Americans Favor Psilocybin For Mental Health Treatment, Study Finds

DA Davidson analyst Brian Holland maintains Freshpet (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FRPT#NASDAQ">FRPT</a>) with a Buy and raises the price target from $183 to $189.

Price Target

Analyst Ratings

FRPT

DA Davidson Maintains Buy on Freshpet, Raises Price Target to $189

Hut 8 Says Its Self-Mining Produced 100 BTC In October, Up From 85 BTC In September; Vega Site Buildout Advancing On Track For Q2 2025 Energization

DA Davidson analyst Michael Shlisky maintains Federal Signal (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FSS#NYSE">FSS</a>) with a Neutral and lowers the price target from $94 to $90.

DA Davidson Maintains Neutral on Federal Signal, Lowers Price Target to $90

DA Davidson maintains NAPCO Security Techs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NSSC#NASDAQ">NSSC</a>) with a Buy and lowers the price target from $55 to $48.

NSSC

DA Davidson Maintains Buy on NAPCO Security Techs, Lowers Price Target to $48

Emerson and its affiliates currently own 57.4% of the Company's outstanding common shares, based on their most recent Schedule 13D filing dated November 5, 2024.
The Board of Directors of AspenTech will follow an appropriate governance process and carefully review the proposal. No action is required by AspenTech shareholders at this time. &nbsp;

AZPN

Aspen Technology Confirms Receipt Of $240/Share Unsolicited Acquisition Proposal From Emerson; Asks Shareholders Not To Take Any Action Pending Review

DA Davidson analyst Brent Thielman maintains Summit Materials (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SUM#NYSE">SUM</a>) with a Neutral and raises the price target from $41 to $47.

DA Davidson Maintains Neutral on Summit Materials, Raises Price Target to $47

PAAS

Pan American Silver Reaffirms Its 2024 Operating Outlook For Annual Production, Cash Costs And AISC, And Capital Expenditures

Pan American Silver (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PAAS#NYSE">PAAS</a>) reported quarterly earnings of $0.32 per share which beat the analyst consensus estimate of $0.21 by 52.38 percent. This is a 3100 percent increase over earnings of $0.01 per share from the same period last year. The company reported quarterly sales of $716.10 million which beat the analyst consensus estimate of $699.01 million by 2.44 percent. This is a 16.19 percent increase over sales of $616.30 million the same period last year.

Earnings Beats

Pan American Silver Q3 2024 Adj EPS $0.32 Beats $0.21 Estimate, Sales $716.10M Beat $699.01M Estimate

DA Davidson analyst Kevin Fitzsimmons maintains Origin Bancorp (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/OBK#NYSE">OBK</a>) with a Buy and lowers the price target from $41 to $38.

DA Davidson Maintains Buy on Origin Bancorp, Lowers Price Target to $38

DA Davidson analyst Gil Luria maintains Palantir Technologies (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PLTR#NYSE">PLTR</a>) with a Neutral and raises the price target from $28 to $47.

PLTR

DA Davidson Maintains Neutral on Palantir Technologies, Raises Price Target to $47

The 2024 U.S. presidential election between Vice President Kamala Harris and former President Donald Trump remains one of the closest in history, raising concerns over whether the U.S. Supreme Court may play a decisive role in <a href="https://www.benzinga.com/topic/2024-election">determining the outcome. </a>
As voters head to the polls, election-related legal battles already hint at the possibility of judicial involvement, The New York Times <a href="https://www.nytimes.com/2024/11/05/us/politics/election-supreme-court.html">reports</a>.
What Happened: Several election cases have reached the Supreme Court in recent weeks, including a decision to allow Virginia's removal of over 1,600 voters from its rolls and rulings affecting candidates and voters in battleground states. 
The court decided against removing Robert F. Kennedy Jr. from ballots in key states and authorized provisional ballots in Pennsylvania, after some mail-in ballots were deemed invalid. These cases showcase the judiciary's cautious approach to electoral involvement, although the court's conservative majority could still play a critical role if a close race sparks significant litigation, according to The New York Times.
Also Read: <a href="https://www.benzinga.com/economics/macro-economic-events/24/11/41759661/us-election-jitters-meet-interest-rate-cut-assurance-why-feds-powell-may-offer-tr">US Election Jitters Meet Interest-Rate Cut Assurance: Why Fed&#8217;s Powell May Offer Traders A Safe Harbor This Week</a>
The Supreme Court's involvement would hinge on an exceptionally narrow vote margin in a critical state, experts say. Prof. Richard Pildes of New York University told The New York Times that a paper-thin margin in a state like Pennsylvania, with its 19 electoral votes, could increase the likelihood of a court ruling influencing the presidential outcome.
Still, experts are cautious, noting that the Supreme Court generally aims to avoid direct involvement in elections.
Beyond the presidential race, the stakes extend to congressional control. Democrats seek to retain the Senate and flip the House, while Republicans push for gains in both chambers. The outcomes in Senate races, including those in Montana and Ohio, could shift control, particularly if Democratic seats in battleground states like Michigan and <a href="https://www.benzinga.com/general/politics/24/11/41725742/2024-election-stakes-potential-sweeps-split-outcomes-in-congressional-presidential-races">Pennsylvania face Republican challenges.</a> 
Why It Matters: A Supreme Court decision might not only impact the presidency but also influence control over Congress, setting a precedent for election litigation. In a scenario reminiscent of the Bush v. Gore case in 2000, if margins are close enough, legal challenges could escalate to the highest court. 
The potential for either party to control both chambers or split Congress suggests significant implications for the future of U.S. legislation and governance, The New York Times notes.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/markets/cryptocurrency/24/11/41756372/robinhoods-election-contracts-hit-200-million-trades-on-election-day">Robinhood&#8217;s Election Contracts Hit 200 Million Trades On Election Day</a></li>
</ul>
This article was generated using artificial intelligence and was reviewed by Benzinga editors.
Photo: Shutterstock

Government

Legal

Supreme Court Could Step In If 2024 Election Remains Deadlocked

SMCI

Super Micro Computer CEO Says Don't Expect Negative Allocation From NVIDIA

Super Micro Computer CEO Says He Has An 'Open Mind' About Separating CEO And Chairman Roles

Gerdau Reports Q3 Adjusted EBITDA Of R$3.0B, Up 14.9% Q/Q

Murchinson Ltd. holds approximately 7.1% of the outstanding shares of Nano Dimension.

NNDM

Murchinson Urges Nano Dimension Shareholders To Vote For Its Independent Nominees; Sends Letter Highlighting Company's Questionable Acquisitions

TD Bank Expects Catastrophe Claims Of $388M After Reinsurance And Before Tax To Be Reflected In Wealth Management & Insurance Segment's Q4 Results

Trump Media &amp; Technology Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DJT#NASDAQ">DJT</a>) reported third-quarter financial results after the market close Tuesday, the same day Donald Trump is facing off against Kamala Harris in the <a href="https://www.benzinga.com/news/24/11/41758791/whats-going-on-with-trump-media-technology-group-stock-tuesday">2024 presidential election.</a>
What Happened: Trump Media &amp; Technology Group announced third-quarter net sales of $1.01 million, down 6% year-over-year, according to data<a href="https://www.benzinga.com/pro/?utm_source=BZprocontent110524&amp;t=be2bearmibe3na1"> from Benzinga Pro.</a>
The company <a href="https://s3.amazonaws.com/sec.irpass.cc/2660/0001140361-24-045260.pdf">said </a>all of its revenue came from advertising on the Truth Social platform in the quarter.
The company reported a loss of 10 cents per share compared to a loss of 30 cents per share in last year's third quarter.
Trump Media &amp; Technology Group, which was co-founded by the former president, highlighted the importance of Trump for the company's success.
"TMTG's success depends in part on the popularity of our brand and the reputation and popularity of President Donald J. Trump. The value of TMTG's brand may diminish if the popularity of President Donald J. Trump were to suffer," the company said.
Trump is able to post politically related posts on any social media site at any time, including outside of Truth Social, the filing said. 
The filing lists a date of Feb. 2, 2025 for when Trump may "terminate the Exclusivity Obligation" with 30 days prior written notice for his non-political posts to appear first on Truth Social.
Did You Know?
<ul>
<li>Congress Is Making Huge Investments. <a href="https://www.benzinga.com/gov-trades/?utm_source=BZprocontent110524">Get Tips On What They Bought And Sold Ahead Of The 2024 Election With Our Easy-to-Use Tool</a></li>
</ul>
What's Next: The quarterly filing said the company plans to roll out its streaming content in three phases.
<ul>
<li>Phase 1: Introduce Truth Social for streaming live TV to the Truth Social app for Android, iOS and Web</li>
<li>Phase 2: Release standalone Truth Social over-the-top streaming apps for phones, tablets and other devices</li>
<li>Phase 3: Release Truth Social streaming apps for home TV</li>
</ul>
The company said it completed phase 1 in August, phase 2 in October and as of Oct. 23, phase 3 has seen the Truth+ streaming platform released on Apple TV, Android TV and Amazon Fire TV.
Future growth initiatives from the company include growing the initial Truth Social platform, increasing product offerings and pursuing strategic acquisitions and/or partnerships.
The company said it plans to expand the business operations globally.
Trump Media &amp; Technology Group ended the third quarter with $672 million in cash, cash equivalents and short-term investments.
DJT Price Action: Shares of Trump Media &amp; Technology Group saw increased volatility Tuesday ahead of the 2024 election with shares halted twice Tuesday.
Shares traded between $31.45 and $40.74 on Tuesday before closing down 1% to $33.94.
The stock is trading 2,.2% higher after hours at $4.69. 
Trump Media &amp; Technology Group stock is likely to experience increased volatility during the week as investors await the results of the 2024 election, with a potential Trump win viewed as a positive for the stock and a Trump loss viewed as a negative for the stock.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/general/politics/24/11/41732623/bakery-that-often-predicts-election-outcomes-has-this-candidate-winning-in-trump-harris-battle-d" target="_blank" rel="noreferrer noopener">Bakery That Often Predicts Election Outcomes Has This Candidate Winning In Trump, Harris Battle: ‘Doughmacracy For All!'</a></li>
</ul>

Social Media

Movers

DJT Stock Volatile On Election Day: Donald Trump's Media Company Reports Q3 Earnings, Growth Initiatives

Jones Trading analyst Jason Weaver maintains Franklin BSP Realty Trust (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FBRT#NYSE">FBRT</a>) with a Buy and maintains $15 price target.

FBRT

Jones Trading Maintains Buy on Franklin BSP Realty Trust, Maintains $15 Price Target

In a report released today, Sujeeva De Silva from Roth MKM maintained a Buy rating on ON Semiconductor (ON – Research Report), with a price target ...

Roth MKM Reaffirms Their Buy Rating on ON Semiconductor (ON)

Craig-Hallum analyst Anthony Stoss maintained a Hold rating on ON Semiconductor (ON – Research Report) today and set a price target of $78.00. The ...

ON Semiconductor (ON) Receives a Hold from Craig-Hallum

DBS analyst Amanda Tan has maintained their bullish stance on ON stock, giving a Buy rating today. Amanda Tan's rating is based on ON Semiconductor...

ON Semiconductor Positioned for Strong Growth and Margin Expansion Driven by Strategic Alignment with Industry Trends

Onsemi's Strategic Bet On Silicon Carbide: The Future Is Bright For EV Adoption

Truist lowered the firm's price target on On Semiconductor (ON) to $89 from $97 but keeps a Buy rating on the shares. The company beat Q3 consensus...

On Semiconductor price target lowered to $89 from $97 at Truist

Is ON Semiconductor A Buy After FQ3'24 Earnings

Stocks with cheap implied volatility – JPM

Bearish flow noted in ON Semiconductor (ON) with 12,175 puts trading, or 1.4x expected. Most active are 11/1 weekly 57 puts and Nov-24 55 puts, wit...

Comments

ON Semiconductor

ON Semiconductor (ON) 옵션

ON Semiconductor (NASDAQ:ON) 주식, 옵션 체인

뉴스

파트너 / 기고자

벤징가 글로벌